Trials / Terminated
TerminatedNCT00939939
Effect of Sitagliptin on Postprandial Lipoprotein Metabolism
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Ludwig-Maximilians - University of Munich · Academic / Other
- Sex
- All
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The goal of the study is to evaluate whether sitagliptin can affect postprandial lipoprotein metabolism in type 2 diabetic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sitagliptin | sitagliptin 100 mg/d for 10 weeks |
| DRUG | glimepiride | glimepiride 1 mg/d for 10 weeks |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2009-07-15
- Last updated
- 2011-06-27
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00939939. Inclusion in this directory is not an endorsement.